期刊文献+

我国国家药物政策制定的研究 被引量:3

Study on the Development of China National Drug Policy
下载PDF
导出
摘要 目的:促进我国尽快制定完善的国家药物政策(NDP)。方法:采取文献研究方法和比较制度分析法,对世界卫生组织的NDP指南和多个典型国家制定的NDP及其国情进行研究。结果与结论:在对比分析各国国情和NDP目标、框架的基础上,提出影响各国NDP制定的主要因素有经济发展水平、医疗保障情况及制药行业发展水平三方面,并根据这些影响因素进一步分析了我国有关国情,建议我国NDP的目标应包括改善药品的可及性、保证药品安全性和提高药品质量、促进药品合理使用、促进制药行业可持续发展、加快中药发展等五方面。 Objective:To promote the development of sound national drug policys(NDPs)of China as soon as possible. Methods:To study the WHO NDP guidelines and typical countries’NDPs and their national situations through literature research and data analysis. Results and Conclusion:Based on the comparison of the national status,the objectives and framework of NDPs of these countries,the major factors influencing the development of NDPs were put forward,such as the level of economic development,the situation of medical security and the development level of the pharmaceutical industry. On this basis,the current status in China was analyzed and targets of the national drug policy were projected including improving drug accessibility,ensuring drug safety, improving drug quality and rational use of medicines,promoting the sustainable development of pharmaceutical industry,and accelerating the development of traditional Chinese medicine.
出处 《中国执业药师》 CAS 2011年第5期38-41,共4页 China Licensed Pharmacist
关键词 国家药物政策 药品可及性 药品可负担性 合理用药 National Drug Policy Drug Accessibility Drug Affordability Rational Use of Medicines
  • 相关文献

参考文献12

  • 1WHO. How to develop and implement a national drug policy[EB/ OL]. [2010-04-16]. http://apps.who.intJmedicinedocs/pdf/s2283e/ s2283e.pdf.
  • 2WHO.WHO Medicines Strategy: 2004-2007, Countries at the core [EB/OL]. [2010-04-16]. http://apps, who. intJmedicinedocs/pdf/ s5571 e/s5571 e.pdf.
  • 3Ministry of Health. National Medicinal Drug Policy for Sri Lanka [EB/OL]. [2010-04-16].http://www.who.int/medicines/areas/policy/NMDP_SriLanka.pdf.
  • 4Australian Department of Health and Ageing. National Medicines Policy 2000 [EB/OL].[2010-04-18].http://www.health.gov.au/internet / main/publishing, nsf/Content/1184A3544D5E9364CA2574 FC0079DC 1 A/$File/nmp2000.pdf.
  • 5India Department of Chemicals and Petrochemicals. National Pharmaceuticals Policy, 2006 Part-A [EB/OL]. [2010-04-18]. http:// medind.nic.in/haa/t07/il/haat07ilpl.pdf.
  • 6India Department of Chemicals and Petrochemicals. Pharmaceutical Policy-2002 [EB/OL]. [2010-04-18]. http://nmcc-vikas.gov.in/ pdf/Policies&Schemes / Central-Government / Policies / Central% 20Pharmaceutical%20Policy.pdf.
  • 7Framework for a Canadian Pharmaceutical Strategy [EB/OL]. [2010-04-20]. http://www, cna-nurses, ca/CNA/documents/pdf/ publications/Framework_Pharm_Strategy_e.pdf.
  • 8F erritorial Ministerial Task Force. National Pharmaceuticals Strategy: Progress Report [EB/OL]. [2010-04- 20]. http://www.hc-sc.gc.ca/hcs-sss/pubs/pharma/2006-nps-snpp/ index-eng.pdf.
  • 9促进印度制药产业发展因素及其深度[N/OL].医药经济报,2006-07-18[2010-07-15].http://in.china-embassy.org/chn/zygx/zykj/zykjjl/t263697.htm.
  • 10邢力.国民税负到底偏高还是偏低[J/OL].理财周刊.(2010-09-17)[2010-07-18].http://finance.sina.com.cn/money/roll/20100917/18338677673.shtml.

共引文献1

同被引文献13

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部